In JoVE (1)
Other Publications (3)
Articles by Robbe Van den Begin in JoVE
定位アブレーションボディ放射線治療のための動的肺腫瘍の追跡 Charles A. Kunos1, Jeffrey M. Fabien1, John P. Shanahan1, Christine Collen2, Thierry Gevaert2, Kenneth Poels2, Robbe Van den Begin2, Benedikt Engels2, Mark De Ridder2 1Department of Radiation Oncology, Summa Cancer Institute, 2Department of Radiation Oncology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel
Other articles by Robbe Van den Begin on PubMed
Preoperative Intensity-modulated and Image-guided Radiotherapy with a Simultaneous Integrated Boost in Locally Advanced Rectal Cancer: Report on Late Toxicity and Outcome Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology. Jan, 2014 | Pubmed ID: 24239243 The addition of chemotherapy to preoperative radiotherapy has been established as the standard of care for patients with cT3-4 rectal cancer. As an alternative strategy, we explored intensity-modulated and image-guided radiotherapy (IMRT-IGRT) with a simultaneous integrated boost (SIB) in a prospective phase II study. Here, we report outcome and late toxicity after a median follow-up of 54 months.
Treating Patients with Real-time Tumor Tracking Using the Vero Gimbaled Linac System: Implementation and First Review Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology. Sep, 2014 | Pubmed ID: 25049177 To report on the first clinical application of a real-time tumor tracking (RTTT) solution based on the Vero SBRT gimbaled linac system for treatment of moving tumors.
Impact of Inadequate Respiratory Motion Management in SBRT for Oligometastatic Colorectal Cancer Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology. Nov, 2014 | Pubmed ID: 25441611 Stereotactic body radiotherapy (SBRT) in oligometastatic colorectal cancer (CRC) resulted in a disappointing 1-year local control rate of 54% in our experience. We aimed to determine the root cause(s).